Tailormade CRISPR-Based Solutions for Therapeutic Applications

Time: 9:00 am
day: Day One


  • Emendo’s nuclease discovery and protein engineering platforms facilitate the development of the optimal editing strategy for each indication
  • Nucleases with unique PAM sequences allow for targeting exclusive genomic sites
  • Discovery of nucleases of various characteristics enables flexibility in choosing delivery vehicles